Ledger Run Expands Senior Leadership to Meet Growing Demand in Clinical Trials

Ledger Run, a creator of a cutting-edge financial operations platform tailored for clinical trials, has recently elevated its executive leadership team in a strategic move to capitalize on increasing market demand. This change marks a significant milestone as the company prepares for amplified growth and aims to enhance its service offerings.

New Executives Join the Team

In a well-timed announcement, Ledger Run introduced three accomplished leaders to its executive roster: Patrick Mizer as Chief Technology Officer (CTO), Dennis Morgan as Chief Financial Officer (CFO), and Jody Quint as Chief Commercial Officer (CCO). These appointments come just six months after CEO John Chinnici took over the reins from co-founder Gary Lubin, reflecting a clear vision for the company's future direction.

Driving Rapid Growth

With Ledger Run witnessing an impressive 50% year-over-year growth, the newly assembled executive team is expected to spearhead a period of hyper-growth for the company. The focus will be on leveraging their extensive backgrounds in technology and business to streamline clinical trial operations.

The innovative ClinRun platform, developed by Ledger Run, is designed to simplify complex financial operations associated with clinical trials. This software solution integrates vital functions like site contracting, budgeting, payments, and forecasting, providing real-time financial transparency for sponsors and contract research organizations (CROs).

During a recent address, CEO John Chinnici expressed optimism about the company's trajectory, noting, "The increasing complexity of trials is driving demand for innovative technology solutions like ClinRun that improves efficiency across the full life cycle of clinical trials. With our impressive leadership team, we are well-positioned to seize the opportunity ahead."

Executive Profiles

Patrick Mizer - CTO

Bringing over 20 years of experience, Mizer has previously helmed technology and product divisions in various high-growth environments, including Storable. His role at Ledger Run is critical as he aims to fortify the engineering foundation and expedite product delivery, which are essential for the organization as it seeks to scale operations.

Dennis Morgan - CFO

Morgan comes with a wealth of expertise from his tenure in several growth-driven technology companies, such as Buddy Media, SHYFT Analytics, and Ellevation Education. His profound financial acumen will guide Ledger Run through this rapid expansion, ensuring sound financial strategies and practices are in place.

Jody Quint - CCO

With extensive experience in the life sciences sector, Quint assumed the CCO role poised to enhance the company’s commercial strategy. Having worked with esteemed organizations like IQVIA and Optum, she is well-equipped to lead teams and drive innovation while focusing on optimizing clinical trial workflows for increased success.

Market Opportunities

The clinical trials support software market is set to grow at an astounding compound annual growth rate (CAGR) of nearly 17% until 2030. This momentum creates a ripe opportunity for Ledger Run, especially with its proven leadership now at the forefront.

The company currently supports over 50 clients, including three of the top ten pharmaceutical companies, facilitating more than 900 studies at 17,000 research sites globally. These figures underscore Ledger Run’s vital role in advancing clinical research through its innovative solutions, making real-time financial transparency a reality.

Industry Conferences

The newly appointed executive team will make its public debut at two significant events: the OCT New England in Boston on October 15-16 and SCOPE Europe in Barcelona during the same dates. Attendees can visit Ledger Run’s booth (#84) for insights into the company’s strategic advancements and innovative solutions.

Conclusion

As Ledger Run embarks on this new chapter with a solidified leadership structure, the spotlight is on their potential to revolutionize clinical trial operations further. With the landscape of clinical trials becoming more complex, solutions like ClinRun are essential to simplifying processes and driving efficiencies that ultimately benefit sponsors and research organizations alike. The future is bright for Ledger Run as it positions itself at the forefront of this burgeoning market.